Send me a link:

*Text messaging rates may apply.

 Dow Down0.19% Nasdaq Up0.45%

Keryx Biopharmaceuticals Inc. (KERX)

-NCM
15.35 0.08(0.52%) Jul 30, 4:00PM EDT
Cash FlowGet Cash Flow for:
View: Annual Data | Quarterly DataAll numbers in thousands
Period EndingMar 31, 2014Dec 31, 2013Sep 30, 2013Jun 30, 2013
Net Income (13,530) (17,668) (15,651) (11,358)
Operating Activities, Cash Flows Provided By or Used In
Depreciation32  20  12  12  
Adjustments To Net Income2,552  3,993  741  638  
Changes In Accounts Receivables(195)156  70  (226)
Changes In Liabilities1,044  (1,129)4,663  3,152  
Changes In Inventories -   -   -   -  
Changes In Other Operating Activities51  2,379  (2,475)490  
Total Cash Flow From Operating Activities (10,046) (12,249) (12,640) (7,292)
Investing Activities, Cash Flows Provided By or Used In
Capital Expenditures(221)(297)(4) -  
Investments(49,665) -  24,294  (24,294)
Other Cash flows from Investing Activities -   -   -   -  
Total Cash Flows From Investing Activities (49,886) (297) 24,290   (24,294)
Financing Activities, Cash Flows Provided By or Used In
Dividends Paid -   -   -   -  
Sale Purchase of Stock109,493  504  209  122  
Net Borrowings -   -   -   -  
Other Cash Flows from Financing Activities -   -   -   -  
Total Cash Flows From Financing Activities 109,493   504   209   122  
Effect Of Exchange Rate Changes -   -   -   -  
Change In Cash and Cash Equivalents 49,561   (12,042) 11,859   (31,464)

Sign Up for a Free Trial to EDGAR Online Premium!
Get the critical business and financial information you need for more than 15,000 U.S. public companies.
Sign Up Now - Learn More

Currency in USD.